Literature DB >> 10401448

Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.

G W Small1, S T Chen, S Komo, L Ercoli, S Bookheimer, K Miller, H Lavretsky, S Saxena, A Kaplan, D Dorsey, W K Scott, A M Saunders, J L Haines, A D Roses, M A Pericak-Vance.   

Abstract

OBJECTIVE: Because subjective memory complaints may indicate subtle functional brain abnormalities, the authors studied the influence of the major genetic risk for Alzheimer's disease, the apolipoprotein E-4 (APOE-4) allele, on self-reports of memory performance in middle-aged and older adults.
METHOD: Subjective and objective assessments of memory performance were compared in relation to the presence or absence of the APOE-4 allele in 39 cognitively intact persons with mild memory complaints.
RESULTS: Subjects with the APOE-4 allele had lower scores on objective verbal memory and on the subjective memory measure for retrospective functioning. Among the subjects in the age range where APOE-4 has its greatest influence on the risk of Alzheimer's disease (55-74 years), the APOE-4 group had lower scores on the subjective memory measure for frequency of forgetting. Moreover, the standardized difference in retrospective functioning scores between the two genetic risk groups increased when the mid-age-range group was examined rather than the whole study group.
CONCLUSIONS: The APOE-4 allele is associated with increased subjective memory impairment in middle-aged and older adults. Longitudinal studies of age-related memory loss should include genetic risk and subjective memory measures as potential predictors of decline.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401448     DOI: 10.1176/ajp.156.7.1035

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  Effects of environmental enrichment on gene expression in the brain.

Authors:  C Rampon; C H Jiang; H Dong; Y P Tang; D J Lockhart; P G Schultz; J Z Tsien; Y Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  The Cognitive Change in Women study (CCW): informant ratings of cognitive change but not self-ratings are associated with neuropsychological performance over 3 years.

Authors:  Rebecca Gavett; Julie E Dunn; Anne Stoddard; Brian Harty; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

3.  Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.

Authors:  N Maritza Dowling; Bruce Hermann; Asenath La Rue; Mark A Sager
Journal:  Neuropsychology       Date:  2010-11       Impact factor: 3.295

4.  Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.

Authors:  Beth E Snitz; Oscar L Lopez; Eric McDade; James T Becker; Ann D Cohen; Julie C Price; Chester A Mathis; William E Klunk
Journal:  J Alzheimers Dis       Date:  2015-09-24       Impact factor: 4.472

5.  Subjective cognitive concerns, episodic memory, and the APOE ε4 allele.

Authors:  Cécilia Samieri; Cécile Proust-Lima; Maria M Glymour; Olivia I Okereke; Rebecca E Amariglio; Reisa A Sperling; Dorene M Rentz; Francine Grodstein
Journal:  Alzheimers Dement       Date:  2014-09-23       Impact factor: 21.566

Review 6.  Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Authors:  Richard D Semba; Qu Tian; Michelle C Carlson; Qian-Li Xue; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-01-26       Impact factor: 10.895

7.  Subjective memory complaints and concurrent memory performance in older patients of primary care providers.

Authors:  Beth E Snitz; Lisa A Morrow; Eric G Rodriguez; Kimberly A Huber; Judith A Saxton
Journal:  J Int Neuropsychol Soc       Date:  2008-11       Impact factor: 2.892

8.  The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge.

Authors:  Nunzio Pomara; Kenneth D Belzer; Raul Silva; Thomas B Cooper; John J Sidtis
Journal:  Psychopharmacology (Berl)       Date:  2008-07-31       Impact factor: 4.530

9.  Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.

Authors:  A G Yip; C Brayne; D Easton; D C Rubinsztein
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

10.  Apolipoprotein E genotype and memory in the sixth decade of life.

Authors:  M R Schultz; M J Lyons; C E Franz; M D Grant; C Boake; K C Jacobson; H Xian; G D Schellenberg; S A Eisen; W S Kremen
Journal:  Neurology       Date:  2008-01-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.